0001054274-11-000001.txt : 20110317
0001054274-11-000001.hdr.sgml : 20110317
20110317115013
ACCESSION NUMBER: 0001054274-11-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110317
DATE AS OF CHANGE: 20110317
EFFECTIVENESS DATE: 20110317
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alliqua, Inc.
CENTRAL INDEX KEY: 0001054274
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 582349413
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1220
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-156928
FILM NUMBER: 11694286
BUSINESS ADDRESS:
STREET 1: 850 THIRD AVENUE
STREET 2: SUITE 1801
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 800-518-4879
MAIL ADDRESS:
STREET 1: 850 THIRD AVENUE
STREET 2: SUITE 1801
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC
DATE OF NAME CHANGE: 20030529
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA CORP
DATE OF NAME CHANGE: 20030219
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA CORP /CA
DATE OF NAME CHANGE: 20000303
D
1
primary_doc.xml
X0704
D
LIVE
0001054274
Alliqua, Inc.
850 THIRD AVENUE
SUITE 1801
NEW YORK
NY
NEW YORK
10022
(646) 218-1450
FLORIDA
HEPALIFE TECHNOLOGIES INC
ZETA CORP
ZETA CORP /CA
Corporation
true
Richard
Rosenblum
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Executive Officer
Director
President and Director of the Issuer
David
Stefansky
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Executive Officer
Director
Chairman of the Issuer
Joseph
Sierchio
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Joseph
M.
Leone
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Michael
Goldberg
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Nochum
Stein
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Kenneth
Pearsen
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Jeffrey
Sklar
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Director
Steven
C.
Berger
850 Third Avenue
Suite 1801
New York
NY
NEW YORK
10022
Executive Officer
Chief Financial Officer of the Issuer
Biotechnology
$1,000,001 - $5,000,000
- 06
false
2011-03-02
false
true
true
false
0
Palladium Capital Advisors, LLC
129400
None
None
230 Park Avenue
Suite 539
New York
NY
NEW YORK
10169
FL
FLORIDA
false
1000000
1000000
0
The Issuer issued 6,250,000 shares of common stock and a five year warrant to purchase 6,250,000 shares of common stock to the investor in exchange for aggregate consideration of $1,000,000.
false
1
154000
true
0
The Issuer issued 437,500 shares of common stock and a five year warrant to purchase 312,500 shares of common stock to the placement agent as consideration for serving as the placement agent.
0
false
Alliqua, Inc.
Richard Rosenblum
Richard Rosenblum
President and Director of the Issuer
2011-03-15